Filed: 11/14/2024ACC: 0001920938-24-000006
📋 What this filing means
BRAIDWELL LP filed this quarterly 13F‑HR report disclosing 81 equity positions with a total reported market value of $3.53B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
81
Positions
$3.53B
Total AUM (reported)
1.45B
Total Shares
Allocation by class
COM$1.78B50.6%
NOTE11/1$215.98M6.1%
NOTE 2.500% 3/1$145.61M4.1%
COM NEW$142.07M4.0%
NOTE11/0$133.26M3.8%
NOTE 0.375% 3/1$111.86M3.2%
SPONSORED ADS$104.55M3.0%
Portfolio Concentration
Top 3$494.85M14.0%
4–10$727.35M20.6%
11–25$1.08B30.5%
Rest$1.23B34.8%
Top 3 weight
14.0%
Top 10 weight
34.6%
Voting Authority Distribution
Total shares with voting rights: 1.45B
Sole
Full voting authority
1.45B
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole81
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings81
Rows:
GUARDANT HEALTH INC
SOLEShares268.25M
TypePRN
Market value$215.98M
6.12%
Sole
268.25M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares140.84M
TypePRN
Market value$145.61M
4.13%
Sole
140.84M
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares140.83M
TypePRN
Market value$133.26M
3.78%
Sole
140.83M
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares3.17M
TypeSH
Market value$119.64M
3.39%
Sole
3.17M
Shared
0.00
None
0.00
NUVASIVE INC
SOLEShares114.21M
TypePRN
Market value$111.86M
3.17%
Sole
114.21M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares2.71M
TypeSH
Market value$106.58M
3.02%
Sole
2.71M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares917.67K
TypeSH
Market value$105.73M
3.00%
Sole
917.67K
Shared
0.00
None
0.00
NEOGENOMICS INC
SOLEShares116.38M
TypePRN
Market value$96.89M
2.75%
Sole
116.38M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares1.64M
TypeSH
Market value$96.52M
2.74%
Sole
1.64M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares3.13M
TypeSH
Market value$90.13M
2.55%
Sole
3.13M
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares92.74M
TypePRN
Market value$82.47M
2.34%
Sole
92.74M
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares92.70M
TypePRN
Market value$82.27M
2.33%
Sole
92.70M
Shared
0.00
None
0.00
ALIGN TECHNOLOGY INC
SOLEShares311.68K
TypeSH
Market value$79.27M
2.25%
Sole
311.68K
Shared
0.00
None
0.00
GUARDANT HEALTH INC
SOLEShares3.34M
TypeSH
Market value$76.67M
2.17%
Sole
3.34M
Shared
0.00
None
0.00
INSULET CORP
SOLEShares63.80M
TypePRN
Market value$76.38M
2.17%
Sole
63.80M
Shared
0.00
None
0.00
LEGEND BIOTECH CORP
SOLEShares1.54M
TypeSH
Market value$75.12M
2.13%
Sole
1.54M
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares1.16M
TypeSH
Market value$73.25M
2.08%
Sole
1.16M
Shared
0.00
None
0.00
KINIKSA PHARMACEUTICALS INTL
SOLEShares2.89M
TypeSH
Market value$72.33M
2.05%
Sole
2.89M
Shared
0.00
None
0.00
PENUMBRA INC
SOLEShares361.43K
TypeSH
Market value$70.23M
1.99%
Sole
361.43K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares73.50M
TypePRN
Market value$70.14M
1.99%
Sole
73.50M
Shared
0.00
None
0.00
MARAVAI LIFESCIENCES HLDGS I
SOLEShares8.35M
TypeSH
Market value$69.42M
1.97%
Sole
8.35M
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares4.87M
TypeSH
Market value$67.89M
1.92%
Sole
4.87M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares2.19M
TypeSH
Market value$64.40M
1.83%
Sole
2.19M
Shared
0.00
None
0.00
REPLIGEN CORP
SOLEShares396.78K
TypeSH
Market value$59.05M
1.67%
Sole
396.78K
Shared
0.00
None
0.00
IRHYTHM TECHNOLOGIES INC
SOLEShares782.56K
TypeSH
Market value$58.10M
1.65%
Sole
782.56K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCSOLE | NOTE11/1 | 268.25M | PRN | $215.98M 6.12% | 268.25M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 140.84M | PRN | $145.61M 4.13% | 140.84M | 0.00 | 0.00 |
NOVOCURE LTDSOLE | NOTE11/0 | 140.83M | PRN | $133.26M 3.78% | 140.83M | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 3.17M | SH | $119.64M 3.39% | 3.17M | 0.00 | 0.00 |
NUVASIVE INCSOLE | NOTE 0.375% 3/1 | 114.21M | PRN | $111.86M 3.17% | 114.21M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 2.71M | SH | $106.58M 3.02% | 2.71M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 917.67K | SH | $105.73M 3.00% | 917.67K | 0.00 | 0.00 |
NEOGENOMICS INCSOLE | NOTE 0.250% 1/1 | 116.38M | PRN | $96.89M 2.75% | 116.38M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 1.64M | SH | $96.52M 2.74% | 1.64M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 3.13M | SH | $90.13M 2.55% | 3.13M | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | NOTE 1.500% 6/1 | 92.74M | PRN | $82.47M 2.34% | 92.74M | 0.00 | 0.00 |
DEXCOM INCSOLE | NOTE 0.375% 5/1 | 92.70M | PRN | $82.27M 2.33% | 92.70M | 0.00 | 0.00 |
ALIGN TECHNOLOGY INCSOLE | COM | 311.68K | SH | $79.27M 2.25% | 311.68K | 0.00 | 0.00 |
GUARDANT HEALTH INCSOLE | COM | 3.34M | SH | $76.67M 2.17% | 3.34M | 0.00 | 0.00 |
INSULET CORPSOLE | NOTE 0.375% 9/0 | 63.80M | PRN | $76.38M 2.17% | 63.80M | 0.00 | 0.00 |
LEGEND BIOTECH CORPSOLE | SPONSORED ADS | 1.54M | SH | $75.12M 2.13% | 1.54M | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 1.16M | SH | $73.25M 2.08% | 1.16M | 0.00 | 0.00 |
KINIKSA PHARMACEUTICALS INTLSOLE | ORD SHS CL A | 2.89M | SH | $72.33M 2.05% | 2.89M | 0.00 | 0.00 |
PENUMBRA INCSOLE | COM | 361.43K | SH | $70.23M 1.99% | 361.43K | 0.00 | 0.00 |
DEXCOM INCSOLE | NOTE 0.250%11/1 | 73.50M | PRN | $70.14M 1.99% | 73.50M | 0.00 | 0.00 |
MARAVAI LIFESCIENCES HLDGS ISOLE | COM CL A | 8.35M | SH | $69.42M 1.97% | 8.35M | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 4.87M | SH | $67.89M 1.92% | 4.87M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 2.19M | SH | $64.40M 1.83% | 2.19M | 0.00 | 0.00 |
REPLIGEN CORPSOLE | COM | 396.78K | SH | $59.05M 1.67% | 396.78K | 0.00 | 0.00 |
IRHYTHM TECHNOLOGIES INCSOLE | COM | 782.56K | SH | $58.10M 1.65% | 782.56K | 0.00 | 0.00 |
Page 1 of 4